CORRECTION article

Front. Pharmacol., 27 March 2025

Sec. Gastrointestinal and Hepatic Pharmacology

Volume 16 - 2025 | https://doi.org/10.3389/fphar.2025.1591086

Corrigendum: Cynaroside ameliorates TNBS-induced colitis by inhibiting intestinal epithelial cell apoptosis via the PI3K/AKT signalling pathway

  • 1. Department of Clinical Laboratory, First Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui, China

  • 2. Anhui Province Key Laboratory of Basic and Translational Research of Inflammation-Related Diseases, First Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui, China

  • 3. Department of Central Laboratory, First Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui, China

  • 4. Department of Clinical Laboratory, The Third the People’s Hospital of Bengbu, Bengbu, Anhui, China

Article metrics

View details

975

Views

312

Downloads

In the published article, there was an error in Figure 7 as published. Two Western blot (WB) strips were misused in Figure 7L (markers: Cas3 and GAPDH). The incorrect strips in Figure 7L were mistakenly used from two strips in Figure 8G (markers: Cas3 and GAPDH). The corrected Figure 7 and its caption appear below.

FIGURE 7

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

Crohn’s disease, cynaroside, IECs apoptosis, colonic organoids, PI3K/AKT

Citation

Huang J, Li J, Geng Z, Yin L, Niu M, Li Q, Liu X, Cheng X, Zhang X, Song X, Wang Y, Wang L, Zuo L and Hu J (2025) Corrigendum: Cynaroside ameliorates TNBS-induced colitis by inhibiting intestinal epithelial cell apoptosis via the PI3K/AKT signalling pathway. Front. Pharmacol. 16:1591086. doi: 10.3389/fphar.2025.1591086

Received

10 March 2025

Accepted

21 March 2025

Published

27 March 2025

Volume

16 - 2025

Edited and reviewed by

Zhenhua Li, Jinan University, China

Updates

Copyright

*Correspondence: Jianguo Hu,

†These authors have contributed equally to this work

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics